Clinical Trial Update: Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating once-daily versus twice-daily mesalamine to induce remission in pediatric ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Mild to Moderate Ulcerative Colitis | Phase 4 | Status: COMPLETED